ClearBridge Investments’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43M | Hold |
342,302
| – | – | 0.03% | 327 |
|
|
2025
Q1 | $37.9M | Buy |
342,302
+23,003
| +7% | +$2.54M | 0.03% | 343 |
|
|
2024
Q4 | $43.6M | Hold |
319,299
| – | – | 0.04% | 340 |
|
|
2024
Q3 | $36.8M | Sell |
319,299
-21,503
| -6% | -$2.48M | 0.03% | 370 |
|
|
2024
Q2 | $46.9M | Hold |
340,802
| – | – | 0.04% | 327 |
|
|
2024
Q1 | $47M | Hold |
340,802
| – | – | 0.04% | 345 |
|
|
2023
Q4 | $44.9M | Buy |
340,802
+28,805
| +9% | +$3.8M | 0.04% | 343 |
|
|
2023
Q3 | $35.1M | Hold |
311,997
| – | – | 0.03% | 356 |
|
|
2023
Q2 | $29.4M | Buy |
311,997
+61,210
| +24% | +$5.77M | 0.03% | 387 |
|
|
2023
Q1 | $25.4M | Hold |
250,787
| – | – | 0.02% | 402 |
|
|
2022
Q4 | $30M | Hold |
250,787
| – | – | 0.03% | 390 |
|
|
2022
Q3 | $26.6M | Hold |
250,787
| – | – | 0.03% | 396 |
|
|
2022
Q2 | $24.4M | Sell |
250,787
-5
| -0% | -$487 | 0.02% | 414 |
|
|
2022
Q1 | $23.5M | Hold |
250,792
| – | – | 0.02% | 446 |
|
|
2021
Q4 | $21.4M | Sell |
250,792
-1,058
| -0.4% | -$90.1K | 0.01% | 467 |
|
|
2021
Q3 | $24.2M | Sell |
251,850
-50
| -0% | -$4.8K | 0.02% | 461 |
|
|
2021
Q2 | $24.5M | Sell |
251,900
-40
| -0% | -$3.89K | 0.02% | 478 |
|
|
2021
Q1 | $24.5M | Buy |
251,940
+40,410
| +19% | +$3.93M | 0.02% | 455 |
|
|
2020
Q4 | $20.3M | Sell |
211,530
-7,970
| -4% | -$764K | 0.02% | 466 |
|
|
2020
Q3 | $21.1M | Buy |
+219,500
| New | +$21.1M | 0.02% | 416 |
|